ISRADIPINE

ISRADIPINE was reported 560 times

ISRADIPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRICHINIASIS 1 0.0625
1 ADRENAL CALCIFICATION 1 0.0588
2 SMALL BOWEL ANGIOEDEMA 6 0.0561
3 ANISOCHROMIA 1 0.0556
4 URINARY GLYCOSAMINOGLYCANS INCREASED 1 0.0370
5 CAMPYLOBACTER COLITIS 3 0.0349
6 DIABETIC AMYOTROPHY 1 0.0333
7 GALLBLADDER CANCER METASTATIC 2 0.0282
8 MENINGITIS ENTEROCOCCAL 2 0.0253
9 DIVERTICULITIS INTESTINAL PERFORATED 8 0.0224
10 ECHOGRAPHY ABNORMAL 1 0.0222
11 PERICARDITIS URAEMIC 1 0.0204
12 LENTIGO MALIGNA STAGE UNSPECIFIED 1 0.0196
13 GASTROINTESTINAL TELANGIECTASIA 1 0.0196
14 HEPATITIS A VIRUS TEST POSITIVE 1 0.0130
15 PRIMARY IMMUNODEFICIENCY SYNDROME 1 0.0123
16 DRUG INTERACTION INHIBITION 1 0.0119
17 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY 1 0.0109
18 LARYNGEAL INFLAMMATION 2 0.0106
19 GASTROENTEROSTOMY 1 0.0092
20 OBSTRUCTIVE SHOCK 1 0.0092
21 NEUROBLASTOMA 3 0.0078
22 PERITONEAL EFFUSION 1 0.0074
23 ADENOVIRUS REACTIVATION 1 0.0069
24 CHYLOTHORAX 5 0.0069
25 TRACHEAL OEDEMA 1 0.0068
26 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 1 0.0066
27 SECONDARY HYPOTHYROIDISM 1 0.0065
28 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
29 GINGIVAL OEDEMA 1 0.0057
30 INFLUENZA B VIRUS TEST POSITIVE 1 0.0055
31 HYPERPARATHYROIDISM PRIMARY 2 0.0055
32 HYPOCHROMASIA 1 0.0050
33 MONONEUROPATHY 1 0.0048
34 LICE INFESTATION 1 0.0048
35 RENAL VESSEL DISORDER 1 0.0047
36 BONE MARROW TRANSPLANT REJECTION 1 0.0045
37 ORAL CONTUSION 1 0.0043
38 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
39 NAIL BED INFECTION 1 0.0042
40 ULNAR NERVE INJURY 1 0.0041
41 GINGIVAL INJURY 1 0.0041
42 MICROCYTOSIS 1 0.0040
43 DNA ANTIBODY POSITIVE 1 0.0040
44 B-CELL APLASIA 1 0.0039
45 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
46 COAGULATION FACTOR DECREASED 1 0.0037
47 SEROSITIS 2 0.0036
48 PNEUMOCYSTIS JIROVECI INFECTION 1 0.0036
49 CHEMICAL BURNS OF EYE 1 0.0036
50 HYPEROSMOLAR STATE 1 0.0035
51 LIVER OPERATION 1 0.0032
52 RENAL HYPERTENSION 1 0.0032
53 VENTRICULAR FAILURE 1 0.0032
54 TYMPANIC MEMBRANE DISORDER 1 0.0031
55 JUVENILE ARTHRITIS 1 0.0030
56 CATHETER SITE BRUISE 1 0.0030
57 SALIVA DISCOLOURATION 1 0.0030
58 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
59 RETINAL VEIN THROMBOSIS 2 0.0029
60 CATHETER REMOVAL 1 0.0028
61 CORONARY ARTERY INSUFFICIENCY 1 0.0028
62 GLOBULINS INCREASED 1 0.0027
63 CLONIC CONVULSION 2 0.0027
64 ERYTHROMELALGIA 1 0.0027
65 STOMAL HERNIA 1 0.0027
66 CENTRAL LINE INFECTION 1 0.0027
67 ENTEROBACTER SEPSIS 1 0.0027
68 CHOROIDITIS 1 0.0027
69 HEPATITIS B VIRUS TEST POSITIVE 1 0.0026
70 ADRENAL GLAND CANCER 1 0.0026
71 PRODUCT SUBSTITUTION 1 0.0025
72 HYPOCAPNIA 1 0.0024
73 PHOTODERMATOSIS 1 0.0024
74 CANDIDA SEPSIS 2 0.0022
75 PULMONARY VASCULAR DISORDER 1 0.0021
76 METAPLASIA 1 0.0021
77 INTESTINAL ANGIOEDEMA 1 0.0021
78 BLOOD URIC ACID DECREASED 1 0.0021
79 VOCAL CORD DYSFUNCTION 1 0.0020
80 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
81 CYST REMOVAL 1 0.0019
82 SCAPULA FRACTURE 1 0.0019
83 HYPOPERFUSION 2 0.0019
84 ASPARTATE AMINOTRANSFERASE DECREASED 1 0.0019
85 HUMAN POLYOMAVIRUS INFECTION 1 0.0019
86 IMMUNE-MEDIATED MYOCARDITIS 3 0.0019
87 RENAL CELL CARCINOMA STAGE UNSPECIFIED 1 0.0018
88 CARBON DIOXIDE DECREASED 2 0.0017
89 DEEP BRAIN STIMULATION 1 0.0017
90 SUPERIOR VENA CAVA SYNDROME 1 0.0017
91 MONOCYTE COUNT DECREASED 2 0.0016
92 HYPERCHLORAEMIA 1 0.0016
93 THYROXINE FREE INCREASED 1 0.0016
94 PORTAL VEIN THROMBOSIS 5 0.0015
95 HYPERMAGNESAEMIA 1 0.0015
96 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 1 0.0015
97 ANISOCYTOSIS 1 0.0015
98 COMPULSIONS 1 0.0015
99 PARANEOPLASTIC SYNDROME 1 0.0015
100 URETERIC OBSTRUCTION 2 0.0015
101 FLUID IMBALANCE 1 0.0014
102 GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0014
103 BRONCHIAL WALL THICKENING 1 0.0014
104 VASOGENIC CEREBRAL OEDEMA 1 0.0014
105 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
106 GRAFT LOSS 1 0.0014
107 BLOOD FOLATE DECREASED 1 0.0014
108 B-CELL TYPE ACUTE LEUKAEMIA 1 0.0014
109 SCOTOMA 1 0.0014
110 ENTEROCOLITIS HAEMORRHAGIC 2 0.0014
111 TRACHEITIS 1 0.0013
112 FOETAL GROWTH RETARDATION 1 0.0013
113 BLOOD FIBRINOGEN INCREASED 1 0.0013
114 WOUND DRAINAGE 1 0.0013
115 POLYPECTOMY 1 0.0013
116 METABOLIC SYNDROME 2 0.0012
117 IGA NEPHROPATHY 2 0.0012
118 HEPATIC CANCER METASTATIC 1 0.0012
119 MALIGNANT HYPERTENSION 1 0.0012
120 LUNG HYPERINFLATION 1 0.0012
121 ABDOMINAL LYMPHADENOPATHY 1 0.0012
122 LARGE FOR DATES BABY 1 0.0011
123 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 1 0.0011
124 AREFLEXIA 3 0.0011
125 ANAEMIA OF CHRONIC DISEASE 1 0.0011
126 PRURIGO 1 0.0011
127 LYMPH NODE PAIN 2 0.0011
128 BRAIN STEM HAEMORRHAGE 1 0.0011
129 BONE MARROW TRANSPLANT 2 0.0011
130 EPIDERMAL NECROSIS 1 0.0010
131 OCCULT BLOOD POSITIVE 2 0.0010
132 TUBULOINTERSTITIAL NEPHRITIS 19 0.0010
133 BLOOD PRESSURE INADEQUATELY CONTROLLED 6 0.0010
134 HYPOCHROMIC ANAEMIA 1 0.0010
135 VASCULAR STENT THROMBOSIS 2 0.0010
136 JOINT SPRAIN 1 0.0010
137 HYDROCELE 1 0.0009
138 HYPERPHOSPHATAEMIA 2 0.0009
139 HEPATITIS ACUTE 6 0.0009
140 KETOSIS 1 0.0009
141 RENAL TUBULAR NECROSIS 9 0.0009
142 OTITIS MEDIA 3 0.0009
143 DEMENTIA WITH LEWY BODIES 1 0.0009
144 CATHETER SITE DISCHARGE 1 0.0009
145 LYMPHOCYTE COUNT ABNORMAL 1 0.0009
146 HEPATIC FIBROSIS 3 0.0009
147 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
148 FOETAL GROWTH RESTRICTION 5 0.0008
149 XEROSIS 1 0.0008
150 AORTIC VALVE REPLACEMENT 1 0.0008
151 HEPATIC NECROSIS 3 0.0008
152 GASTRIC ULCER PERFORATION 1 0.0008
153 BLOOD BILIRUBIN ABNORMAL 1 0.0008
154 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 2 0.0008
155 ABDOMINAL OPERATION 1 0.0008
156 ASPERGILLOSIS 1 0.0008
157 SERUM FERRITIN INCREASED 4 0.0008
158 CARBON DIOXIDE INCREASED 1 0.0007
159 RENAL ARTERY STENOSIS 1 0.0007
160 BEZOAR 1 0.0007
161 BILIARY TRACT DISORDER 1 0.0007
162 CHRONIC FATIGUE SYNDROME 1 0.0007
163 ANTIPSYCHOTIC DRUG LEVEL INCREASED 2 0.0007
164 ALVEOLITIS 1 0.0007
165 PNEUMATOSIS INTESTINALIS 2 0.0007
166 DERMATITIS BULLOUS 5 0.0007
167 ADENOVIRUS INFECTION 2 0.0007
168 MUTISM 1 0.0007
169 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
170 SMALL CELL LUNG CANCER 1 0.0007
171 NEPHROGENIC SYSTEMIC FIBROSIS 2 0.0007
172 REBOUND ACID HYPERSECRETION 2 0.0007
173 PORTAL HYPERTENSION 2 0.0006
174 GASTROSTOMY 1 0.0006
175 BRONCHIAL DISORDER 1 0.0006
176 HEPATIC ENCEPHALOPATHY 6 0.0006
177 TRANSCRIPTION MEDICATION ERROR 1 0.0006
178 PNEUMONIA VIRAL 2 0.0006
179 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1 0.0006
180 CUSHINGOID 2 0.0006
181 SKULL FRACTURE 1 0.0006
182 CRYPTOCOCCOSIS 1 0.0006
183 VASOPLEGIA SYNDROME 1 0.0006
184 HYPERVOLAEMIA 3 0.0006
185 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 2 0.0006
186 ANTIBODY TEST POSITIVE 1 0.0006
187 VENA CAVA THROMBOSIS 1 0.0006
188 TONSILLECTOMY 1 0.0006
189 ENTERITIS INFECTIOUS 1 0.0006
190 FIXED ERUPTION 1 0.0006
191 TONGUE COATED 1 0.0006
192 BLOOD CHLORIDE INCREASED 1 0.0006
193 VERTIGO POSITIONAL 1 0.0006
194 KYPHOSIS 1 0.0006
195 MUSCLE CRAMP 1 0.0006
196 ESSENTIAL HYPERTENSION 1 0.0005
197 BODY TEMPERATURE ABNORMAL 1 0.0005
198 METAMORPHOPSIA 1 0.0005
199 PNEUMOPERITONEUM 1 0.0005
200 BLADDER SPASM 1 0.0005
201 SMALL INTESTINAL PERFORATION 1 0.0005
202 BILE DUCT OBSTRUCTION 1 0.0005
203 ALCOHOL INTERACTION 1 0.0005
204 CELL DEATH 1 0.0005
205 AZOTAEMIA 2 0.0005
206 ARTHRITIS BACTERIAL 2 0.0005
207 RENAL MASS 1 0.0005
208 HYPERPARATHYROIDISM 1 0.0005
209 ATRIAL THROMBOSIS 1 0.0005
210 CAPILLARY LEAK SYNDROME 1 0.0005
211 DRUG-INDUCED LIVER INJURY 15 0.0005
212 LUNG ABSCESS 1 0.0005
213 HALLUCINATIONS, MIXED 2 0.0005
214 DEVICE CONNECTION ISSUE 1 0.0005
215 HEPATIC NEOPLASM MALIGNANT 1 0.0005
216 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
217 HAEMORRHAGIC ANAEMIA 2 0.0005
218 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
219 HEPATOCELLULAR DAMAGE 1 0.0004
220 STATUS EPILEPTICUS 5 0.0004
221 REBOUND EFFECT 5 0.0004
222 COMPUTERISED TOMOGRAM ABNORMAL 1 0.0004
223 LICHENOID KERATOSIS 1 0.0004
224 NEPHROTIC SYNDROME 3 0.0004
225 BUNDLE BRANCH BLOCK RIGHT 2 0.0004
226 BILIRUBIN CONJUGATED INCREASED 1 0.0004
227 PANCREATITIS CHRONIC 1 0.0004
228 SINUS OPERATION 1 0.0004
229 LONG QT SYNDROME 1 0.0004
230 GASTROINTESTINAL OBSTRUCTION 1 0.0004
231 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
232 SLOW SPEECH 1 0.0004
233 BRONCHITIS CHRONIC 1 0.0004
234 GLOMERULONEPHRITIS 1 0.0004
235 DIABETIC NEUROPATHY 2 0.0004
236 INTRAVENTRICULAR HAEMORRHAGE 1 0.0004
237 ANEURYSM 2 0.0004
238 FLUID INTAKE REDUCED 2 0.0004
239 HYPERPARATHYROIDISM SECONDARY 1 0.0004
240 VASODILATATION 1 0.0004
241 OSTEITIS 1 0.0004
242 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
243 DYSLIPIDAEMIA 2 0.0004
244 CANCER PAIN 1 0.0004
245 HEPATOSPLENOMEGALY 1 0.0004
246 CATHETER SITE PAIN 1 0.0004
247 VENTRICULAR DYSFUNCTION 1 0.0004
248 PROTEIN TOTAL INCREASED 1 0.0004
249 YAWNING 1 0.0004
250 ALCOHOL POISONING 1 0.0004
251 ANAL FISSURE 2 0.0004
252 PULMONARY THROMBOSIS 4 0.0004
253 RHEUMATOID NODULE 1 0.0004
254 THYROID NEOPLASM 1 0.0004
255 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
256 GASTRIC ULCER HAEMORRHAGE 2 0.0004
257 PROCTITIS 1 0.0004
258 FACE OEDEMA 6 0.0004
259 RESPIRATORY SYMPTOM 1 0.0004
260 PANCREATIC CARCINOMA METASTATIC 1 0.0004
261 DUODENAL ULCER HAEMORRHAGE 1 0.0003
262 SPEECH DISORDER DEVELOPMENTAL 1 0.0003
263 VOMITING PROJECTILE 1 0.0003
264 HYPOVOLAEMIA 2 0.0003
265 BACTERAEMIA 4 0.0003
266 ODYNOPHAGIA 2 0.0003
267 HEPATITIS CHOLESTATIC 2 0.0003
268 FIBROSIS 1 0.0003
269 HEPATIC STEATOSIS 6 0.0003
270 EYELIDS PRURITUS 1 0.0003
271 FLANK PAIN 3 0.0003
272 BLOOD CREATININE DECREASED 1 0.0003
273 ORTHOPNOEA 1 0.0003
274 PANCREATITIS ACUTE 7 0.0003
275 HEPATOMEGALY 3 0.0003
276 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 1 0.0003
277 CYTOLYTIC HEPATITIS 1 0.0003
278 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
279 CYTOKINE RELEASE SYNDROME 6 0.0003
280 TOXIC SKIN ERUPTION 3 0.0003
281 WOUND DEHISCENCE 1 0.0003
282 APLASIA PURE RED CELL 1 0.0003
283 DIFFICULTY IN WALKING 1 0.0003
284 LEFT VENTRICULAR FAILURE 1 0.0003
285 THROMBOPHLEBITIS 1 0.0003
286 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
287 JAUNDICE CHOLESTATIC 1 0.0003
288 DIVERTICULUM 2 0.0003
289 METABOLIC ACIDOSIS 9 0.0003
290 FIBRIN D DIMER INCREASED 1 0.0003
291 APPENDICECTOMY 1 0.0003
292 GRAFT VERSUS HOST DISEASE 2 0.0003
293 CAROTID ARTERY OCCLUSION 1 0.0003
294 THROMBOCYTOSIS 1 0.0003
295 BLINDNESS TRANSIENT 2 0.0003
296 FREEZING PHENOMENON 1 0.0003
297 LEUKOENCEPHALOPATHY 1 0.0003
298 PAROSMIA 2 0.0003
299 CARDIOPULMONARY FAILURE 1 0.0003
300 TORSADE DE POINTES 2 0.0003
301 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
302 ATRIAL FLUTTER 2 0.0003
303 CHRONIC KIDNEY DISEASE 19 0.0002
304 CANDIDIASIS 1 0.0002
305 TRIGEMINAL NEURALGIA 1 0.0002
306 SENSORY LOSS 2 0.0002
307 INTERNATIONAL NORMALISED RATIO DECREASED 1 0.0002
308 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
309 EXTRAVASATION 1 0.0002
310 DRUG LEVEL INCREASED 4 0.0002
311 COAGULOPATHY 4 0.0002
312 CONGESTIVE CARDIOMYOPATHY 1 0.0002
313 PULSELESS ELECTRICAL ACTIVITY 1 0.0002
314 HAEMODIALYSIS 2 0.0002
315 ABSCESS LIMB 1 0.0002
316 SHOULDER OPERATION 1 0.0002
317 METASTATIC NEOPLASM 1 0.0002
318 BLOOD MAGNESIUM DECREASED 2 0.0002
319 PYELONEPHRITIS 2 0.0002
320 MONOPLEGIA 1 0.0002
321 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
322 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
323 NEUROTOXICITY 4 0.0002
324 HYPERKALAEMIA 8 0.0002
325 BLOOD CREATINE INCREASED 1 0.0002
326 GOUT 4 0.0002
327 DRUG EFFECT DELAYED 1 0.0002
328 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
329 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
330 END STAGE RENAL DISEASE 4 0.0002
331 RESPIRATORY DISTRESS 6 0.0002
332 MENTAL STATUS CHANGES 6 0.0002
333 NEPHROGENIC ANAEMIA 1 0.0002
334 ARTHRITIS INFECTIVE 1 0.0002
335 AGRANULOCYTOSIS 4 0.0002
336 COORDINATION ABNORMAL 3 0.0002
337 PERFORMANCE STATUS DECREASED 1 0.0002
338 SKIN ABRASION 1 0.0002
339 DIALYSIS 3 0.0002
340 PRE-ECLAMPSIA 1 0.0002
341 FAECAL INCONTINENCE 1 0.0002
342 ACUTE RESPIRATORY FAILURE 4 0.0002
343 ATELECTASIS 2 0.0002
344 GUILLAIN-BARRE SYNDROME 1 0.0002
345 DIZZINESS POSTURAL 2 0.0002
346 FLUID OVERLOAD 3 0.0002
347 THROMBOTIC MICROANGIOPATHY 2 0.0002
348 SPRUE-LIKE ENTEROPATHY 1 0.0002
349 STAPHYLOCOCCAL SEPSIS 1 0.0002
350 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
351 INFLAMMATORY MARKER INCREASED 1 0.0002
352 DRUG INTERACTION 32 0.0002
353 ABDOMINAL TENDERNESS 1 0.0002
354 PRODUCT PHYSICAL ISSUE 4 0.0002
355 SUBARACHNOID HAEMORRHAGE 2 0.0002
356 MOTOR DYSFUNCTION 2 0.0002
357 PHLEBITIS 1 0.0002
358 PRODUCT COLOUR ISSUE 1 0.0002
359 CEREBRAL ISCHAEMIA 1 0.0002
360 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
361 FAILURE TO THRIVE 1 0.0002
362 C-REACTIVE PROTEIN INCREASED 7 0.0002
363 TONSILLITIS 1 0.0002
364 BLOOD BILIRUBIN INCREASED 5 0.0002
365 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1 0.0002
366 HYPERKERATOSIS 1 0.0002
367 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
368 BLOOD UREA INCREASED 3 0.0002
369 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
370 ANGIOPATHY 1 0.0002
371 MACULAR OEDEMA 1 0.0002
372 PULMONARY ALVEOLAR HAEMORRHAGE 1 0.0002
373 PRODUCT LEAKAGE 1 0.0002
374 ACUTE PULMONARY OEDEMA 1 0.0002
375 BLOOD CALCIUM DECREASED 2 0.0002
376 PREMATURE LABOUR 1 0.0002
377 PERIORBITAL SWELLING 1 0.0002
378 GRANULOCYTOPENIA 1 0.0002
379 NEUROLOGICAL SYMPTOM 1 0.0002
380 CORONARY ARTERY BYPASS 1 0.0002
381 ENTEROCOLITIS 1 0.0002
382 ORTHOSTATIC HYPOTENSION 3 0.0002
383 DYSKINESIA 7 0.0002
384 METABOLIC DISORDER 1 0.0002
385 ELECTROLYTE IMBALANCE 2 0.0002
386 VASCULITIS 2 0.0002
387 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
388 ACUTE KIDNEY INJURY 26 0.0002
389 LYMPHOCYTE COUNT DECREASED 3 0.0002
390 ASPARTATE AMINOTRANSFERASE INCREASED 9 0.0002
391 CATARACT OPERATION 1 0.0002
392 CHOLECYSTITIS 2 0.0002
393 PROTHROMBIN TIME PROLONGED 1 0.0002
394 HEARING IMPAIRED 1 0.0002
395 ENDOPHTHALMITIS 1 0.0002
396 PREMATURE BABY 5 0.0002
397 RENAL FAILURE ACUTE 7 0.0002
398 TENSION 1 0.0002
399 CYTOPENIA 2 0.0002
400 PIGMENTATION DISORDER 1 0.0002
401 ABASIA 4 0.0002
402 OLIGURIA 1 0.0002
403 INFUSION SITE SWELLING 1 0.0002
404 THERAPEUTIC RESPONSE CHANGED 1 0.0002
405 HAEMATEMESIS 4 0.0002
406 PULMONARY FIBROSIS 3 0.0002
407 CHOLESTASIS 3 0.0002
408 HAEMOGLOBIN ABNORMAL 1 0.0002
409 POOR QUALITY DRUG ADMINISTERED 1 0.0002
410 LACTIC ACIDOSIS 5 0.0002
411 ANGINA UNSTABLE 1 0.0002
412 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
413 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
414 HAEMATOCRIT DECREASED 3 0.0002
415 RENAL FAILURE 20 0.0002
416 CARDIAC FAILURE ACUTE 1 0.0001
417 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
418 METASTASES TO LYMPH NODES 1 0.0001
419 ULCER HAEMORRHAGE 1 0.0001
420 OEDEMA PERIPHERAL 18 0.0001
421 ACUTE HEPATIC FAILURE 2 0.0001
422 HYPERTENSION 31 0.0001
423 BLOOD TESTOSTERONE DECREASED 1 0.0001
424 INFARCTION 1 0.0001
425 ONYCHOCLASIS 1 0.0001
426 RESPIRATION ABNORMAL 1 0.0001
427 JOINT EFFUSION 1 0.0001
428 HYPOGLYCAEMIA 7 0.0001
429 RIGHT VENTRICULAR FAILURE 1 0.0001
430 DEVICE OCCLUSION 2 0.0001
431 HYPOXIA 5 0.0001
432 BLINDNESS UNILATERAL 2 0.0001
433 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
434 PRODUCT SUPPLY ISSUE 1 0.0001
435 LIVER FUNCTION TEST INCREASED 3 0.0001
436 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
437 ORAL DISORDER 1 0.0001
438 ASCITES 4 0.0001
439 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
440 DUODENAL ULCER PERFORATION 1 0.0001
441 THERAPY NON-RESPONDER 6 0.0001
442 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1 0.0001
443 BLOOD POTASSIUM DECREASED 4 0.0001
444 PEMPHIGOID 1 0.0001
445 COLITIS 5 0.0001
446 HAEMODYNAMIC INSTABILITY 1 0.0001
447 BOWEL MOVEMENT IRREGULARITY 1 0.0001
448 PERICARDIAL EFFUSION 3 0.0001
449 HAEMOLYSIS 1 0.0001
450 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
451 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
452 EJECTION FRACTION DECREASED 2 0.0001
453 HYPOALBUMINAEMIA 1 0.0001
454 BLOOD ALBUMIN DECREASED 1 0.0001
455 RENAL CYST 1 0.0001
456 GINGIVAL PAIN 1 0.0001
457 BLOOD PRESSURE FLUCTUATION 3 0.0001
458 INTERSTITIAL LUNG DISEASE 6 0.0001
459 SHOCK HAEMORRHAGIC 1 0.0001
460 ESCHERICHIA INFECTION 1 0.0001
461 MENSTRUAL DISORDER 1 0.0001
462 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
463 EMBOLISM 1 0.0001
464 SECOND PRIMARY MALIGNANCY 1 0.0001
465 FUNGAL INFECTION 4 0.0001
466 EOSINOPHIL COUNT INCREASED 1 0.0001
467 CARDIO-RESPIRATORY ARREST 5 0.0001
468 INFUSION SITE ERYTHEMA 1 0.0001
469 FACIAL PARALYSIS 1 0.0001
470 VITAMIN D DECREASED 1 0.0001
471 SKIN HYPERPIGMENTATION 1 0.0001
472 ANURIA 1 0.0001
473 URINE OUTPUT DECREASED 1 0.0001
474 EOSINOPHILIA 2 0.0001
475 LYMPHADENOPATHY 4 0.0001
476 RESPIRATORY RATE INCREASED 1 0.0001
477 DEVELOPMENTAL DELAY 1 0.0001
478 LEUKOCYTOSIS 2 0.0001
479 PALLOR 3 0.0001
480 PNEUMONIA BACTERIAL 1 0.0001
481 UROSEPSIS 1 0.0001
482 IRON DEFICIENCY ANAEMIA 1 0.0001
483 BLOOD CREATININE INCREASED 7 0.0001
484 NEPHROPATHY 1 0.0001
485 EPISTAXIS 8 0.0001
486 DYSARTHRIA 4 0.0001
487 GASTRIC ULCER 2 0.0001
488 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
489 RED BLOOD CELL COUNT DECREASED 3 0.0001
490 HYPOTENSION 21 0.0001
491 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
492 LOWER LIMB FRACTURE 2 0.0001
493 SINUS BRADYCARDIA 1 0.0001
494 DYSTONIA 2 0.0001
495 URINARY INCONTINENCE 3 0.0001
496 HOSPICE CARE 1 0.0001
497 HYPOTONIA 1 0.0001
498 HEPATIC FAILURE 3 0.0001
499 PERITONITIS BACTERIAL 1 0.0001
500 HYPOTHERMIA 1 0.0001
501 BONE MARROW FAILURE 2 0.0001
502 NEUTROPHIL COUNT DECREASED 4 0.0001
503 EUPHORIC MOOD 1 0.0001
504 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 1 0.0001
505 PERITONITIS 2 0.0001
506 PULMONARY HYPERTENSION 2 0.0001
507 COMPLETED SUICIDE 8 0.0001
508 INTENTIONAL DRUG MISUSE 2 0.0001
509 PRODUCT ODOUR ABNORMAL 1 0.0001
510 TRANSFUSION 1 0.0001
511 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
512 CYSTITIS 3 0.0001
513 BODY HEIGHT DECREASED 1 0.0001
514 HEREDITARY ANGIOEDEMA 1 0.0001
515 DECREASED ACTIVITY 1 0.0001
516 FAECES DISCOLOURED 2 0.0001
517 OESOPHAGITIS 1 0.0001
518 WOUND INFECTION 1 0.0001
519 MELAENA 2 0.0001
520 TOOTH FRACTURE 1 0.0001
521 VISUAL ACUITY REDUCED 3 0.0001
522 HYPERTENSIVE CRISIS 1 0.0001
523 MALNUTRITION 1 0.0001
524 PULMONARY OEDEMA 4 0.0001
525 OCULAR DISCOMFORT 1 0.0001
526 FISTULA 1 0.0001
527 CHROMATURIA 2 0.0001
528 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
529 MYOCARDIAL ISCHAEMIA 1 0.0001
530 DERMATITIS CONTACT 1 0.0001
531 SHOCK 2 0.0001
532 LETHARGY 5 0.0001
533 METASTASES TO LUNG 1 0.0001
534 RENAL DISORDER 4 0.0001
535 BURNING SENSATION 6 0.0001
536 HEART RATE DECREASED 3 0.0001
537 SPLENOMEGALY 1 0.0001
538 HYPERLIPIDAEMIA 1 0.0001
539 POLYNEUROPATHY 1 0.0001
540 RENAL IMPAIRMENT 7 0.0001
541 ADRENAL INSUFFICIENCY 1 0.0001
542 PRESYNCOPE 2 0.0001
543 PLEURAL EFFUSION 5 0.0001
544 NO THERAPEUTIC RESPONSE 1 0.0001
545 AGITATION 6 0.0001
546 MUSCLE SPASTICITY 1 0.0001
547 CARDIOMEGALY 1 0.0001
548 SPINAL OPERATION 1 0.0001
549 HYPERCALCAEMIA 1 0.0001
550 PHARYNGITIS 1 0.0001
551 PNEUMONIA ASPIRATION 2 0.0001
552 POISONING 1 0.0001
553 DERMATITIS ALLERGIC 1 0.0001
554 MUSCLE ATROPHY 1 0.0001
555 INJECTION SITE IRRITATION 1 0.0001
556 HEPATITIS 2 0.0001
557 INFUSION SITE PAIN 1 0.0001
558 ANOREXIA 1 0.0001
559 TOXICITY TO VARIOUS AGENTS 13 0.0001
560 PLATELET COUNT INCREASED 1 0.0001
561 NODULE 1 0.0001
562 MUCOSAL INFLAMMATION 2 0.0001
563 JOINT STIFFNESS 2 0.0001
564 BEDRIDDEN 1 0.0001
565 EYE HAEMORRHAGE 1 0.0001
566 JAUNDICE 2 0.0001
567 PRODUCT TASTE ABNORMAL 1 0.0001
568 OEDEMA 4 0.0001
569 TREATMENT NONCOMPLIANCE 4 0.0001
570 CORONARY ARTERY OCCLUSION 1 0.0001
571 PERIPHERAL COLDNESS 1 0.0001
572 RESPIRATORY ARREST 2 0.0001
573 ANAPHYLACTIC REACTION 4 0.0001
574 HUNGER 1 0.0001
575 HAEMOPTYSIS 2 0.0001
576 WOUND 2 0.0001
577 THROMBOCYTOPENIA 8 0.0001
578 CARPAL TUNNEL SYNDROME 1 0.0001
579 BLOOD TEST ABNORMAL 1 0.0001
580 OSTEOARTHRITIS 3 0.0001
581 PAIN IN JAW 2 0.0001
582 SUBDURAL HAEMATOMA 1 0.0001
583 ANGINA PECTORIS 2 0.0001
584 CARDIOGENIC SHOCK 1 0.0001
585 HYPERTHYROIDISM 1 0.0001
586 DEVICE DISLOCATION 3 0.0001
587 INJECTION SITE HAEMATOMA 1 0.0001
588 FLUSHING 7 0.0001
589 LIVER FUNCTION TEST ABNORMAL 2 0.0001
590 GASTROENTERITIS 1 0.0001
591 BLOOD COUNT ABNORMAL 1 0.0001
592 OSTEOPENIA 1 0.0001
593 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
594 DRUG DISPENSING ERROR 1 0.0001
595 EPILEPSY 2 0.0001
596 BLOOD PRESSURE INCREASED 10 0.0001
597 HIP ARTHROPLASTY 1 0.0001
598 THYROID DISORDER 1 0.0001
599 ANKLE FRACTURE 1 0.0001
600 TENDONITIS 1 0.0001
601 LUNG INFECTION 1 0.0001
602 THERAPY PARTIAL RESPONDER 1 0.0001
603 NERVOUS SYSTEM DISORDER 2 0.0001
604 PULMONARY EMBOLISM 6 0.0001
605 RESPIRATORY TRACT CONGESTION 1 0.0001
606 ULCER 1 0.0001
607 PREMATURE DELIVERY 1 0.0001
608 OBESITY 1 0.0001
609 SCIATICA 1 0.0001
610 MOVEMENT DISORDER 2 0.0001
611 MUSCLE TIGHTNESS 1 0.0001
612 DEEP VEIN THROMBOSIS 4 0.0001
613 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
614 CHOLELITHIASIS 2 0.0001
615 METASTASES TO BONE 1 0.0001
616 HEART RATE INCREASED 6 0.0001
617 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
618 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
619 CYTOMEGALOVIRUS INFECTION 1 0.0001
620 URINARY RETENTION 2 0.0001
621 CELLULITIS 3 0.0001
622 UPPER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
623 CANDIDA INFECTION 1 0.0001
624 HAEMOGLOBIN DECREASED 6 0.0001
625 HAEMATURIA 2 0.0001
626 PARANOIA 1 0.0001
627 MULTI-ORGAN FAILURE 1 0.0001
628 PYREXIA 20 0.0001
629 NIGHTMARE 2 0.0001
630 ANAEMIA 11 0.0001
631 NERVOUSNESS 3 0.0001
632 METASTASES TO LIVER 1 0.0001
633 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
634 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
635 DYSPNOEA 32 0.0001
636 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
637 TACHYCARDIA 5 0.0001
638 GALLBLADDER DISORDER 1 0.0001
639 CEREBRAL HAEMORRHAGE 2 0.0001
640 MOBILITY DECREASED 4 0.0001
641 TOOTHACHE 1 0.0001
642 OSTEOMYELITIS 1 0.0001
643 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
644 PELVIC PAIN 1 0.0001
645 BONE DISORDER 1 0.0001
646 RESPIRATORY FAILURE 4 0.0001
647 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
648 RESTLESSNESS 2 0.0001
649 BRONCHITIS 4 0.0001
650 PANCYTOPENIA 3 0.0001
651 BACTERIAL INFECTION 1 0.0001
652 HYPONATRAEMIA 3 0.0001
653 ASTHENIA 20 0.0001
654 DYSPNOEA EXERTIONAL 2 0.0001
655 FLATULENCE 3 0.0001
656 UNEVALUABLE EVENT 4 0.0001
657 MUSCULOSKELETAL DISORDER 1 0.0001
658 DEHYDRATION 7 0.0001
659 FEELING JITTERY 1 0.0001
660 POST PROCEDURAL COMPLICATION 1 0.0001
661 HERNIA 1 0.0001
662 ERUCTATION 1 0.0001
663 PRESCRIBED OVERDOSE 1 0.0001
664 ABDOMINAL PAIN 12 0.0001
665 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
666 HAEMORRHOIDS 1 0.0001
667 ABNORMAL BEHAVIOUR 2 0.0001
668 SPINAL FRACTURE 1 0.0000
669 CARDIAC FAILURE 4 0.0000
670 CONFUSIONAL STATE 8 0.0000
671 STOMATITIS 3 0.0000
672 EXTRA DOSE ADMINISTERED 2 0.0000
673 TASTE DISORDER 1 0.0000
674 BLINDNESS 2 0.0000
675 SINUSITIS 5 0.0000
676 CARDIAC ARREST 4 0.0000
677 TOOTH LOSS 1 0.0000
678 POLLAKIURIA 2 0.0000
679 ROAD TRAFFIC ACCIDENT 2 0.0000
680 MOUTH ULCERATION 1 0.0000
681 HALLUCINATION, VISUAL 1 0.0000
682 CEREBROVASCULAR ACCIDENT 8 0.0000
683 RETCHING 1 0.0000
684 IMPAIRED WORK ABILITY 1 0.0000
685 HYPERHIDROSIS 6 0.0000
686 RECTAL HAEMORRHAGE 2 0.0000
687 BALANCE DISORDER 4 0.0000
688 SEPTIC SHOCK 2 0.0000
689 BLOOD PRESSURE DECREASED 3 0.0000
690 TOOTH DISORDER 1 0.0000
691 NEOPLASM MALIGNANT 3 0.0000
692 HEPATOTOXICITY 1 0.0000
693 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
694 HEART RATE IRREGULAR 1 0.0000
695 HYPOKALAEMIA 2 0.0000
696 COGNITIVE DISORDER 2 0.0000
697 COUGH 12 0.0000
698 ARRHYTHMIA 2 0.0000
699 FALL 14 0.0000
700 PRODUCTIVE COUGH 2 0.0000
701 CEREBRAL INFARCTION 1 0.0000
702 LUNG DISORDER 2 0.0000
703 LIVER INJURY 1 0.0000
704 ENCEPHALOPATHY 1 0.0000
705 EXTRAPYRAMIDAL DISORDER 1 0.0000
706 SYNCOPE 4 0.0000
707 COVID-19 7 0.0000
708 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
709 ACNE 3 0.0000
710 CARDIOVASCULAR DISORDER 1 0.0000
711 LOSS OF CONSCIOUSNESS 5 0.0000
712 DRUG RESISTANCE 1 0.0000
713 ERYTHEMA 8 0.0000
714 OFF LABEL USE 34 0.0000
715 SKIN ULCER 1 0.0000
716 RASH GENERALISED 1 0.0000
717 HAEMATOMA 1 0.0000
718 RESPIRATORY TRACT INFECTION 1 0.0000
719 DEAFNESS 1 0.0000
720 ECZEMA 2 0.0000
721 APPLICATION SITE ERYTHEMA 1 0.0000
722 GASTRITIS 1 0.0000
723 BRADYCARDIA 2 0.0000
724 PLATELET COUNT DECREASED 4 0.0000
725 CARDIAC FAILURE CONGESTIVE 3 0.0000
726 FEAR 1 0.0000
727 PAIN OF SKIN 1 0.0000
728 DRY MOUTH 3 0.0000
729 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
730 SKIN LESION 1 0.0000
731 HAEMATOCHEZIA 2 0.0000
732 ABNORMAL DREAMS 1 0.0000
733 VOMITING 17 0.0000
734 TREMOR 6 0.0000
735 DIVERTICULITIS 1 0.0000
736 FEELING COLD 1 0.0000
737 DEMENTIA 1 0.0000
738 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
739 MUSCULAR WEAKNESS 4 0.0000
740 URINARY TRACT INFECTION 6 0.0000
741 CONVULSION 2 0.0000
742 HYPERSOMNIA 1 0.0000
743 PANCREATIC CARCINOMA 1 0.0000
744 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
745 DECREASED APPETITE 8 0.0000
746 DYSSTASIA 1 0.0000
747 SURGERY 2 0.0000
748 PNEUMONIA 11 0.0000
749 ACUTE MYOCARDIAL INFARCTION 1 0.0000
750 LABORATORY TEST ABNORMAL 1 0.0000
751 RENAL INJURY 1 0.0000
752 CATARACT 2 0.0000
753 GASTROINTESTINAL DISORDER 3 0.0000
754 RESPIRATORY DISORDER 1 0.0000
755 HYPOAESTHESIA 5 0.0000
756 ADVERSE DRUG REACTION 3 0.0000
757 APHASIA 1 0.0000
758 CORONARY ARTERY DISEASE 1 0.0000
759 THERAPEUTIC RESPONSE DECREASED 2 0.0000
760 CONDITION AGGRAVATED 10 0.0000
761 NAUSEA 26 0.0000
762 DISCOMFORT 2 0.0000
763 FEELING HOT 2 0.0000
764 DIARRHOEA 21 0.0000
765 WEIGHT DECREASED 9 0.0000
766 CONSTIPATION 7 0.0000
767 CARDIAC DISORDER 3 0.0000
768 SWELLING 3 0.0000
769 BONE DENSITY DECREASED 1 0.0000
770 BLOOD GLUCOSE INCREASED 6 0.0000
771 PARAESTHESIA 5 0.0000
772 ANXIETY 9 0.0000
773 NEUROPATHY PERIPHERAL 3 0.0000
774 GAIT DISTURBANCE 6 0.0000
775 HYPOTHYROIDISM 1 0.0000
776 HIP FRACTURE 1 0.0000
777 RHINORRHOEA 2 0.0000
778 IMPAIRED HEALING 1 0.0000
779 OSTEONECROSIS 1 0.0000
780 EYE DISORDER 1 0.0000
781 STAPHYLOCOCCAL INFECTION 1 0.0000
782 INFUSION RELATED REACTION 2 0.0000
783 FEBRILE NEUTROPENIA 2 0.0000
784 VIRAL INFECTION 1 0.0000
785 TYPE 2 DIABETES MELLITUS 1 0.0000
786 NEUTROPENIA 4 0.0000
787 CHEST DISCOMFORT 3 0.0000
788 FEELING ABNORMAL 7 0.0000
789 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
790 DELIRIUM 1 0.0000
791 ABDOMINAL DISTENSION 3 0.0000
792 RASH MACULAR 1 0.0000
793 INJURY 2 0.0000
794 DRUG INEFFECTIVE 37 0.0000
795 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
796 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
797 INFECTION 4 0.0000
798 CRYING 1 0.0000
799 HYPERGLYCAEMIA 1 0.0000
800 PANIC ATTACK 1 0.0000
801 MALAISE 12 0.0000
802 DYSURIA 1 0.0000
803 EYE SWELLING 1 0.0000
804 HEPATIC FUNCTION ABNORMAL 1 0.0000
805 HALLUCINATION 2 0.0000
806 INTESTINAL OBSTRUCTION 1 0.0000
807 ARTHRALGIA 11 0.0000
808 RHEUMATOID ARTHRITIS 3 0.0000
809 DEPRESSION 6 0.0000
810 DIABETES MELLITUS 2 0.0000
811 HOSPITALISATION 4 0.0000
812 SEIZURE 3 0.0000
813 CHILLS 3 0.0000
814 DISORIENTATION 1 0.0000
815 SOMNOLENCE 5 0.0000
816 ABDOMINAL PAIN UPPER 5 0.0000
817 DIZZINESS 12 0.0000
818 RHABDOMYOLYSIS 1 0.0000
819 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
820 WITHDRAWAL SYNDROME 1 0.0000
821 PAIN IN EXTREMITY 7 0.0000
822 SKIN EXFOLIATION 2 0.0000
823 HYPOACUSIS 1 0.0000
824 FATIGUE 18 0.0000
825 DEVICE LEAKAGE 1 0.0000
826 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
827 ANGIOEDEMA 1 0.0000
828 HEADACHE 14 0.0000
829 WEIGHT INCREASED 5 0.0000
830 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
831 SUICIDAL IDEATION 2 0.0000
832 TINNITUS 1 0.0000
833 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
834 CHEST PAIN 4 0.0000
835 BACK PAIN 5 0.0000
836 BLOOD CHOLESTEROL INCREASED 1 0.0000
837 OCULAR HYPERAEMIA 1 0.0000
838 DISEASE RECURRENCE 1 0.0000
839 MULTIPLE SCLEROSIS 1 0.0000
840 PRURITUS 8 0.0000
841 ATRIAL FIBRILLATION 2 0.0000
842 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
843 LEUKOPENIA 1 0.0000
844 MALIGNANT NEOPLASM PROGRESSION 2 0.0000
845 PERIPHERAL SWELLING 3 0.0000
846 INFLAMMATION 1 0.0000
847 HAEMORRHAGE 2 0.0000
848 DEPRESSED MOOD 1 0.0000
849 INSOMNIA 5 0.0000
850 DEATH 16 0.0000
851 DRUG EFFECT DECREASED 1 0.0000
852 RASH PRURITIC 1 0.0000
853 INFLUENZA 2 0.0000
854 SEPSIS 2 0.0000
855 URTICARIA 3 0.0000
856 OXYGEN SATURATION DECREASED 1 0.0000
857 ASTHMA 2 0.0000
858 MYALGIA 3 0.0000
859 PRODUCT SUBSTITUTION ISSUE 1 0.0000
860 PALPITATIONS 2 0.0000
861 NASAL CONGESTION 1 0.0000
862 PRODUCT DOSE OMISSION ISSUE 5 0.0000
863 DISEASE PROGRESSION 2 0.0000
864 WHEEZING 1 0.0000
865 IRRITABILITY 1 0.0000
866 JOINT SWELLING 2 0.0000
867 VISUAL IMPAIRMENT 2 0.0000
868 RASH 7 0.0000
869 AMNESIA 1 0.0000
870 PSORIASIS 2 0.0000
871 DRY SKIN 2 0.0000
872 PRODUCT QUALITY ISSUE 2 0.0000
873 HEPATIC ENZYME INCREASED 1 0.0000
874 VISION BLURRED 2 0.0000
875 MEMORY IMPAIRMENT 2 0.0000
876 INJECTION SITE REACTION 1 0.0000
877 DEVICE MALFUNCTION 1 0.0000
878 SLEEP DISORDER 1 0.0000
879 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
880 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
881 THERAPY INTERRUPTED 1 0.0000
882 SKIN BURNING SENSATION 1 0.0000
883 DYSGEUSIA 1 0.0000
884 HOT FLUSH 1 0.0000
885 ARTHRITIS 1 0.0000
886 INJECTION SITE BRUISING 1 0.0000
887 PROSTATE CANCER 1 0.0000
888 THROMBOSIS 1 0.0000
889 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
890 INFLUENZA LIKE ILLNESS 1 0.0000
891 DRUG DOSE OMISSION 2 0.0000
892 ABDOMINAL DISCOMFORT 2 0.0000
893 MUSCULOSKELETAL STIFFNESS 1 0.0000
894 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
895 MUSCLE SPASMS 2 0.0000
896 ADVERSE EVENT 1 0.0000
897 OROPHARYNGEAL PAIN 1 0.0000
898 HYPERSENSITIVITY 2 0.0000
899 BREAST CANCER 1 0.0000
900 PRODUCT USE ISSUE 2 0.0000
901 DYSPHAGIA 1 0.0000
902 CONTUSION 1 0.0000
903 DRUG INTOLERANCE 1 0.0000
904 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
905 OVERDOSE 2 0.0000
906 INCORRECT DOSE ADMINISTERED 2 0.0000
907 EMOTIONAL DISTRESS 1 0.0000
908 INJECTION SITE PAIN 2 0.0000
909 PAIN 4 0.0000
910 MYOCARDIAL INFARCTION 1 0.0000
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
912 NO ADVERSE EVENT 1 0.0000
913 NASOPHARYNGITIS 1 0.0000
914 ALOPECIA 1 0.0000
915 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000